News Home

Press Releases

Supply Update

Subscribe


Downloads
TIMELINE OF INNOVATION

CORPORATE FACT SHEET


Media Contacts

  • Priscilla Harlan
    Senior Director, Corporate Communications
    Lantheus Medical Imaging
    978-671-8854

  • Michele Rozen
    Pure Communications
    617-730-8284

Molybdenum-99 Supply Updates

Recent Press Releases
01/20/10 LANTHEUS MEDICAL IMAGING, INC.  LAUNCHES ABLAVAR™ (GADOFOSVESET TRISODIUM), A NEW DIAGNOSTIC MAGNETIC RESONANCE ANGIOGRAPHY AGENT
10/08/09 DATA FEATURING GADOFOSVESET TRISODIUM, THE FIRST AND ONLY MRA
BLOOD POOL AGENT APPROVED IN THE U.S., PRESENTED AT MRA-CLUB 09:
21ST ANNUAL INTERNATIONAL CONFERENCE ON MAGNETIC RESONANCE ANGIOGRAPHY
9/17/09 LANTHEUS MEDICAL IMAGING, INC. INITIATES PHASE 1 STUDY EVALUATING
SAFETY AND DOSIMETRY OF NOVEL HEART FAILURE IMAGING AGENT
8/14/09 LANTHEUS CONTINUES TO ADDRESS INDUSTRY SHORTAGE OF Mo-99 RESULTING FROM PROLONGED NRU REACTOR SHUTDOWN

© 2010 Lantheus Medical Imaging, Inc.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.
ABLAVAR™, Cardiolite® and DEFINITY® are registered trademarks of Lantheus Medical Imaging, Inc.
Any unlicensed use of these trademarks is expressly prohibited under the U.S. Trademark Act.
Intended for U.S. Residents Only